MAIT cells are innate-like T cells known for their semi-invariant TCR that recognizes vitamin B metabolites presented by MR1. While the involvement of TCR and cytokines in development and activation of MAIT cells is well documented, the contribution of co-receptors, including SLAM family receptors, remains poorly understood. This study revealed that CD2 and its ligands, CD48 in mice and CD58 in humans, were crucial for MAIT cell maturation and antigen-driven activation, but not for their responses to cytokines. Cis interactions of CD2 with its ligands on the same cell were essential for activation, with trans interactions contributing in some contexts. A natural subset of human MAIT cells lacking CD2 displayed reduced activation responses to antigen. Human CD48 recognized 2B4 rather than CD2, dampening TCR signal strength and activation of human MAIT cells. Thus, the interplay between CD2 and its ligands is pivotal for MAIT cell development and activation, highlighting potential approaches for treating human diseases implicating MAIT cells.
Skip Nav Destination
Article navigation
1 December 2025
Article Contents
Article|
September 30 2025
CD2 and its ligands are involved in development and activation of MAIT cells
Kaiwen Zhu
,
Kaiwen Zhu
(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing - original draft, Writing - review & editing)
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
2Department of Medicine,
McGill University
, Montréal, Canada
Search for other works by this author on:
Jiayu Dou
,
Jiayu Dou
(Data curation, Formal analysis, Methodology, Resources, Software, Visualization, Writing - original draft)
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
2Department of Medicine,
McGill University
, Montréal, Canada
Search for other works by this author on:
Bin Li
,
Bin Li
(Methodology, Resources)
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
Search for other works by this author on:
Jin Qian
,
Jin Qian
(Resources, Validation, Writing - review & editing)
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
Search for other works by this author on:
Ming-Chao Zhong
,
Ming-Chao Zhong
(Investigation, Methodology)
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
Search for other works by this author on:
Zhenghai Tang
,
Zhenghai Tang
(Methodology, Writing - review & editing)
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
Search for other works by this author on:
Yan Lu
,
(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing - review & editing)
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
3Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology,
Guangzhou Medical University
, Guangzhou, China
4
The Second Affiliated Hospital, Guangzhou Medical University
, Guangzhou, China
Yan Lu: [email protected]
Search for other works by this author on:
André Veillette
(Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Supervision, Visualization, Writing - original draft, Writing - review & editing)
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
2Department of Medicine,
McGill University
, Montréal, Canada
5Department of Medicine,
University of Montréal
, Montréal, Canada
Correspondence to André Veillette: [email protected]
Search for other works by this author on:
Kaiwen Zhu
https://orcid.org/0000-0003-0249-0747
Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing - original draft, Writing - review & editing
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
2Department of Medicine,
McGill University
, Montréal, Canada
Jiayu Dou
https://orcid.org/0009-0009-7553-7594
Data curation, Formal analysis, Methodology, Resources, Software, Visualization, Writing - original draft
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
2Department of Medicine,
McGill University
, Montréal, Canada
Bin Li
https://orcid.org/0000-0001-6987-4636
Methodology, Resources
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
Jin Qian
https://orcid.org/0000-0003-4555-2207
Resources, Validation, Writing - review & editing
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
Ming-Chao Zhong
https://orcid.org/0000-0002-6315-0597
Investigation, Methodology
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
Zhenghai Tang
https://orcid.org/0009-0004-8191-330X
Methodology, Writing - review & editing
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
Yan Lu
https://orcid.org/0000-0002-5893-6114
Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing - review & editing
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
3Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology,
Guangzhou Medical University
, Guangzhou, China
4
The Second Affiliated Hospital, Guangzhou Medical University
, Guangzhou, China
André Veillette
https://orcid.org/0000-0003-1159-4345
Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Supervision, Visualization, Writing - original draft, Writing - review & editing
1Laboratory of Molecular Oncology,
Institut de Recherches Cliniques de Montréal (IRCM)
, Montréal, Canada
2Department of Medicine,
McGill University
, Montréal, Canada
5Department of Medicine,
University of Montréal
, Montréal, Canada
Correspondence to André Veillette: [email protected]
Yan Lu: [email protected]
Disclosures: The authors declare no competing interests exist.
Received:
February 25 2025
Revision Received:
July 11 2025
Accepted:
September 10 2025
Online ISSN: 1540-9538
Print ISSN: 0022-1007
Funding
Funder(s):
Canadian Institutes of Health Research
- Award Id(s): MT-14429,MOP-82906,FDN-143338,PJT-178314,PJT-183593
Funder(s):
Institut de Recherche Clinique De Montréal
Funder(s):
Chinese Science Council
Funder(s):
Cole Foundation
Funder(s):
Canada Research Chair
Funder(s):
National Institutes of Health
- Award Id(s): MR1/5-OP-RU,CD1d/PBS-57,75N93020D00005
© 2025 Zhu et al.
2025
Zhu et al.
This article is distributed under the terms as described at https://rupress.org/pages/terms102024/.
J Exp Med (2025) 222 (12): e20250431.
Article history
Received:
February 25 2025
Revision Received:
July 11 2025
Accepted:
September 10 2025
Citation
Kaiwen Zhu, Jiayu Dou, Bin Li, Jin Qian, Ming-Chao Zhong, Zhenghai Tang, Yan Lu, André Veillette; CD2 and its ligands are involved in development and activation of MAIT cells. J Exp Med 1 December 2025; 222 (12): e20250431. doi: https://doi.org/10.1084/jem.20250431
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your Institution
1,007
Views
Email alerts
Advertisement